[Hyper-remnant-like particles (RLP) lipoproteinemia].
Tanaka
A
A
Third Department of Internal Medicine, Tokyo Medical and Dental University.
Ai
M
M
D001053:Apolipoproteins / Q000097:blood*; D002784:Cholesterol; D004035:Diet Therapy; D004040:Dietary Carbohydrates / Q000009:adverse effects; D005081:Exercise Therapy; D006801:Humans; D006951:Hyperlipoproteinemias / Q000175:diagnosis / Q000209:etiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008074:Lipoproteins / Q000097:blood*; D019518:Postprandial Period; D011379:Prognosis; D014280:Triglycerides / Q000097:blood*
D001053:Apolipoproteins; D004040:Dietary Carbohydrates; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D014280:Triglycerides; C112017:remnant-like particle cholesterol; D002784:Cholesterol